Gottlieb: Vaccine should be widely available by mid-2021
The former FDA commissioner says young, healthy Americans should expect to be able to get vaccinated by the second or third quarter of next year.
Food and Drug Administration
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired November 22, 2020, on "Face the Nation."
Pfizer asks U.S. regulators to OK emergency use of COVID vaccine
With the coronavirus surging around the U.S. and the world, the pressure is on for regulators to make a speedy decision.
Trials show Oxford's COVID vaccine works well in older adults
Scientists working with AstraZeneca say they're "delighted" with the latest human trial data, but they're "not in a rush."
Pfizer says vaccine 95% effective, will seek FDA's okay "within days"
It's the latest hopeful news for a world desperate to turn the tide on the coronavirus pandemic that has killed more than 1.3 million people globally, and almost 250,000 in the U.S. alone.
FDA approves at-home rapid coronavirus test for emergency use
The test will require a prescription, likely limiting its initial use.
11/16/20: Red and Blue
Moderna says their COVID vaccine highly successful; FBI: massive rise in hate crimes in 2019
Moderna's COVID-19 vaccine is 94.5% effective
American pharmaceutical company Moderna announced on Monday that its COVID-19 vaccine candidate is nearly 95% effective. The news comes one week after Pfizer announced its inoculations are also successful. CBS News chief medical correspondent Dr. Jon LaPook has the latest.
Moderna says COVID-19 vaccine nearly 95% effective
Moderna says it has developed a coronavirus vaccine that's nearly 95% effective, and with emergency approval from the FDA it could start distributing the shots to high-risk patients and health care workers as soon as December. Dr. Jon LaPook reports.
Coronavirus vaccine trials provide new hope
Preliminary results show a 94.5% effectiveness rate for Moderna's coronavirus vaccine in Phase 3 trials. The company expects to request emergency use authorization from the FDA within a few weeks. Dr. Jon LaPook reports.
Pfizer gearing up to distribute COVID-19 vaccine
"My biggest fear is that we're dealing with a surge at the same time that we're trying to vaccinate," said New Jersey Health Commissioner Judith Persichilli.
FDA approves emergency use of monoclonal antibody for COVID-19
Early results suggest it may help clear the coronavirus sooner and possibly cut hospitalizations in people with mild to moderate COVID-19.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired November 8, 2020, on "Face the Nation."
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired November 1, 2020, on "Face the Nation."
Pfizer to seek OK for COVID-19 vaccine as soon as next month
Nearly all planned 44,000 participants enrolled in final-stage trial. If found safe, vaccine could see use in November.
Challenges of COVID-19 vaccine distribution
The earliest a coronavirus vaccine is expected to be ready for FDA authorization is the end of November. The CDC has already given states $200 million to prepare for vaccine distribution — but will that be enough? Dr. Tara Narula finds out whether the U.S. has the infrastructure in place to safely and efficiently get people the vaccine.
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired October 25, 2020, on "Face the Nation."
FDA approves remdesivir to treat COVID-19
The Food and Drug Administration has approved remdesivir for the treatment of the coronavirus, and it comes as some cities across the country are seeing spikes in COVID-19 cases. Janet Shamlian reports.
Purdue Pharma settlement marks second guilty plea for company
The plea bargain does not foreclose future criminal charges against the Sackler family owners and Purdue's executives. 60 Minutes has covered the opioid epidemic extensively.
Experts fear COVID surge will get worse
Experts are warning that they expect to see newly confirmed cases of coronavirus soar in the coming weeks, and that Americans should brace for a several "tough months" ahead. Dr. Luiza Petre, a cardiologist and assistant professor of cardiology at Mount Sinai School of Medicine, joins CBSN to discuss the latest on the virus.
Gottlieb says "biggest wave" of infections still to come
The former FDA commissioner says the U.S. has "two or three very hard months ahead of us."
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired October 18, 2020, on "Face the Nation."
Gottlieb predicts "a lot of death and disease" as COVID cases rise
The former FDA commissioner says the U.S. is "in a difficult situation heading into the fall" as the virus surges in parts of the country
Transcript: Scott Gottlieb on "Face the Nation"
The following is a transcript of an interview with former FDA Commissioner Scott Gottlieb that aired October 11, 2020, on "Face the Nation."
FDA's new vaccine guidance pushes approval past election
President Trump said Monday that a vaccine is coming "momentarily," but the FDA says more safety monitoring comes first.
Trump promised to lower prices for Americans. Here's what the data shows.
Hurricane Isaias makes landfall on Gulf Coast as Category 2 storm
Trump announces Russia will release millions of tons of diesel to help with costs
Pentagon's plan to livestream execution sparks intense backlash
Live
Iran's Houthi allies step up deadly attacks on Saudi Arabia
NYPD body camera footage shows aftermath of ICE agent shooting
Panama struck by 2 powerful earthquakes, U.S. Geological Survey says
Katie Zacharia is Trump's pick for next White House press secretary
